Equillium (EQ) Treasury Shares (2023 - 2024)
Equillium (EQ) reported Treasury Shares of $298385.0 for Q4 2024, little changed year-over-year from $298385.0 in Q1 2024, and little changed quarter-over-quarter from $298385.0 in Q3 2024.
Equillium (EQ) Treasury Shares (2023 - 2024) Analysis & Trends
Equillium (EQ) has 2 years of Treasury Shares data on file, last reported at $298385.0 in Q4 2024.
- Treasury Shares for Q4 2024 came in at $298385.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2024 was $298385.0 (changed 0.0% YoY), and the FY2024 annual result was $298385.0, changed 0.0% from the prior year.
- Treasury Shares steadied at $298385.0 in Q4 2024 per EQ's latest filing, from $298385.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $298385.0 in Q3 2023 and troughed at $298385.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 298,385.00 |
| Dec 31, 2024 | 298,385.00 |
| Sep 30, 2024 | 298,385.00 |
| Sep 30, 2024 | 298,385.00 |
| Jun 30, 2024 | 298,385.00 |
| Jun 30, 2024 | 298,385.00 |
| Mar 31, 2024 | 298,385.00 |
| Mar 31, 2024 | 298,385.00 |
| Dec 31, 2023 | 298,385.00 |
| Dec 31, 2023 | 298,385.00 |
| Sep 30, 2023 | 298,385.00 |
| Sep 30, 2023 | 298,385.00 |